| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$186,589,533 |
|
|
|
Indirect Value
|
$47,040,306 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-10-09 |
4 |
AS |
$41.68 |
$2,505,470 |
D/D |
(60,000) |
1,476,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
61,600 |
1,974,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-07-10 |
4 |
OE |
$1.43 |
$100,079 |
D/D |
70,000 |
1,546,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-07-10 |
4 |
AS |
$39.65 |
$2,775,939 |
D/D |
(70,000) |
1,476,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-08-14 |
4 |
OE |
$1.43 |
$100,079 |
D/D |
70,000 |
1,546,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-08-14 |
4 |
AS |
$37.62 |
$2,633,808 |
D/D |
(70,000) |
1,476,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-09-11 |
4 |
OE |
$1.43 |
$100,079 |
D/D |
70,000 |
1,546,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-09-11 |
4 |
AS |
$37.90 |
$2,655,712 |
D/D |
(70,000) |
1,476,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-10-09 |
4 |
OE |
$1.43 |
$253,655 |
D/D |
70,000 |
1,546,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-11-13 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,546,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-11-13 |
4 |
S |
$41.90 |
$2,952,780 |
D/D |
(70,000) |
1,476,049 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-12-11 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,588,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2007-12-11 |
4 |
S |
$46.35 |
$3,254,930 |
D/D |
(70,000) |
1,518,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-01-08 |
4 |
S |
$47.77 |
$3,360,490 |
D/D |
(70,000) |
1,518,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-01-08 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,588,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-02-12 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,588,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-02-12 |
4 |
S |
$45.08 |
$3,183,707 |
D/D |
(70,000) |
1,518,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-03-11 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,588,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-03-11 |
4 |
S |
$46.28 |
$3,240,943 |
D/D |
(70,000) |
1,518,457 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-04-08 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,607,445 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2008-04-08 |
4 |
S |
$52.23 |
$3,662,091 |
D/D |
(70,000) |
1,537,445 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-05-13 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,607,445 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-05-13 |
4 |
S |
$53.60 |
$3,763,828 |
D/D |
(70,000) |
1,537,445 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-06-10 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,619,437 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-06-10 |
4 |
S |
$53.84 |
$3,778,785 |
D/D |
(70,000) |
1,549,437 |
0 |
- |
|
367 Records found
|
|
Page 5 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
